Eli Lilly Said to Play Down Risk of Top Pill
112414
Internal documents show that the company knew of serious side effects of Zyprexa, its best-selling medication for schizophrenia.
54194
The bearish argument against investing in Eli Lilly
79075
Eli Lilly pushed Zyprexa, a drug for schizophrenia and bipolar disorder, as a treatment for older patients with dementia, according to marketing materials.
402815
NEW YORK -- Pharmaceutical company Eli Lilly and Co. on Thursday issued 2007 earnings estimates that are below Wall Street's current expectations.
606892
NEW YORK -- Eli Lilly and Co. has downplayed for about 10 years the risks associated with Zyprexa, which treats schizophrenia, The New York Times said on its website yesterday, citing internal documents from the drug maker and e-mail messages of its managers.
193008
Two recent studies that suggested oral contraceptives reduced a woman&#39;s risk of heart disease and cancer seemed to take conventional wisdom and stand it on its head.
718380
Risk is knocking Big Pharma stocks down. They won't be getting up anytime soon.
729020
Eli Lilly and Co. LLY.N on Thursday  said that it expects 2005 earnings to rise as higher sales of  its newer drugs offset a decline in its top-selling  schizophrenia drug Zyprexa.
527417
Some want tighter control of ads, in part to stem overuse of pills.
339894
Drugmaker Eli Lilly and Co. LLY.N on  Thursday said it will eliminate up to 575 U.S. positions,  representing 2 percent of its U.S. work force, in order to  streamline operations and reduce costs.
216500
Eli Lilly and Co. on Thursday said one of its experimental drugs was comparably effective in a mid-stage trial as the company's widely used Zyprexa treatment, but without weight gains seen with Zyprexa.
28075
Eli Lilly and Co  plans to submit a U.S. application next week for its experimental blood-clot preventer prasugrel, the most important drug in its pipeline, a company spokesman said on Wednesday.
362559
Drug investors may be wishing they could pop two pills and feel better in the morning. The latest headache hit last week when Pfizer joined the rash of drug companies announcing problems with their products.
388672
Eli Lilly & Co  said on Friday that it had won approval to market its blockbuster osteoporosis drug to post-menopausal women who are at high risk for invasive breast cancer.
475875
The risk of blood clots in the legs and lungs may be higher for women using the birth-control patch instead of the pill, according to a warning on the product's label disclosed Wednesday.
675913
Eli Lilly and Co. said its strategy of staying independent and plowing money into research should pay off in 2005, with profits expected to jump 8 percent to 12 percent over 2004 and nine new drugs in advanced human testing.
20825
Shares of Indianapolis-based drugmaker  Eli Lilly and Co. LLY.N, maker of antidepressant drug Prozac,  nudged nearly 1 percent lower on Friday.